Clinical Trials in Turin, Italy
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
AstraZeneca4,300 enrolled727 locationsNCT05774951
Recruiting
Not Applicable
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Brain Metastases, Adult
A.O.U. Città della Salute e della Scienza70 enrolled6 locationsNCT05689619